Margaret Borys joined Shionogi Inc. in April 2022 as Senior Vice President and Chief Commercial Officer and is a member of the Executive Committee.
Ms. Borys is a seasoned commercial leader with 30 years of experience in driving strategy, execution and operations across pharmaceutical, medical device, consumer healthcare and animal health industries. Most recently, she was the Chief Commercial Officer for a biotech startup based in Boston.
Ms. Borys has held numerous executive and senior leadership positions in companies including Sanofi, Pfizer, Wyeth, Pharmacia and Arthur Andersen.
Ms. Borys received a bachelor’s degree with highest honors in accounting and computer science from Rutgers UniversityOpen in a new tab, holds an MBA from Columbia UniversityOpen in a new tab and is a certified public accountant.
This person is not in any offices
Shionogi
9 followers
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.